These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Impact of microbiota and host immunologic response on the efficacy of anticholinergic treatment for urgency urinary incontinence. Gabriel I; Delaney ML; Au M; Courtepatte A; Bry L; Minassian VA Int Urogynecol J; 2023 Dec; 34(12):3041-3050. PubMed ID: 37837459 [TBL] [Abstract][Full Text] [Related]
13. The urinary microbiome in women with mixed urinary incontinence compared to similarly aged controls. Komesu YM; Richter HE; Carper B; Dinwiddie DL; Lukacz ES; Siddiqui NY; Sung VW; Zyczynski HM; Ridgeway B; Rogers RG; Arya LA; Mazloomdoost D; Gantz MG; Int Urogynecol J; 2018 Dec; 29(12):1785-1795. PubMed ID: 29909556 [TBL] [Abstract][Full Text] [Related]
14. Bladder bacterial diversity differs in continent and incontinent women: a cross-sectional study. Price TK; Lin H; Gao X; Thomas-White KJ; Hilt EE; Mueller ER; Wolfe AJ; Dong Q; Brubaker L Am J Obstet Gynecol; 2020 Nov; 223(5):729.e1-729.e10. PubMed ID: 32380174 [TBL] [Abstract][Full Text] [Related]
15. Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence. Richter HE; Amundsen CL; Erickson SW; Jelovsek JE; Komesu Y; Chermansky C; Harvie HS; Albo M; Myers D; Gregory WT; Wallace D; J Urol; 2017 Oct; 198(4):890-896. PubMed ID: 28501541 [TBL] [Abstract][Full Text] [Related]